119 related articles for article (PubMed ID: 31486887)
1. Primary peritoneal serous papillary carcinoma: a case series.
Blontzos N; Vafias E; Vorgias G; Kalinoglou N; Iavazzo C
Arch Gynecol Obstet; 2019 Oct; 300(4):1023-1028. PubMed ID: 31486887
[TBL] [Abstract][Full Text] [Related]
2. Primary peritoneal serous papillary carcinoma: clinical and laboratory characteristics.
Iavazzo C; Vorgias G; Katsoulis M; Kalinoglou N; Dertimas V; Akrivos T
Arch Gynecol Obstet; 2008 Jul; 278(1):53-6. PubMed ID: 18488238
[TBL] [Abstract][Full Text] [Related]
3. Primary peritoneal serous papillary carcinoma: a clinical and pathological study.
Liu Q; Lin JX; Shi QL; Wu B; Ma HH; Sun GQ
Pathol Oncol Res; 2011 Sep; 17(3):713-9. PubMed ID: 21647781
[TBL] [Abstract][Full Text] [Related]
4. Long-term survival after paclitaxel plus platinum-based combination chemotherapy for extraovarian peritoneal serous papillary carcinoma: is it different from that for ovarian serous papillary cancer?
Ayhan A; Taskiran C; Yigit-Celik N; Bozdag G; Gultekin M; Usubutun A; Guler N; Yuce K
Int J Gynecol Cancer; 2006; 16(2):484-9. PubMed ID: 16681715
[TBL] [Abstract][Full Text] [Related]
5. [A case of peritoneal serous papillary carcinoma].
Takeuchi N; Sakata Y; Nishida Y; Nomura Y; Makino T; Maeda T; Tada H; Kimoto T; Ueno S; Fujiwara K
Gan To Kagaku Ryoho; 2011 Aug; 38(8):1337-40. PubMed ID: 21829076
[TBL] [Abstract][Full Text] [Related]
6. Remission with carboplatin of paclitaxel resistant primary peritoneal papillary serous carcinoma: case report.
Herrada J; Kudelka AP; Tornos C; Shin DM; Kavanagh JJ; Edwards CL; Verschraegen CF
Eur J Gynaecol Oncol; 1997; 18(1):39-41. PubMed ID: 9061321
[TBL] [Abstract][Full Text] [Related]
7. Primary peritoneal serous papillary carcinoma: a new epidemiologic trend? A matched-case comparison with ovarian serous papillary cancer.
Halperin R; Zehavi S; Langer R; Hadas E; Bukovsky I; Schneider D
Int J Gynecol Cancer; 2001; 11(5):403-8. PubMed ID: 11737473
[TBL] [Abstract][Full Text] [Related]
8. Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy for the treatment of primary peritoneal serous carcinoma: Results of a Chinese retrospective study.
Sun JH; Ji ZH; Peng KW; Wu HT; Zhang Q; Yonemura Y; Li Y
Int J Hyperthermia; 2016 May; 32(3):289-97. PubMed ID: 26982735
[TBL] [Abstract][Full Text] [Related]
9. Papillary serous carcinoma of peritoneum: presentation of 2 cases.
Ruiz-Tovar J; Pérez de Oteyza J; Rojo R; Collado MV; García Villanueva A
Clin Transl Oncol; 2006 Oct; 8(10):758-60. PubMed ID: 17074676
[TBL] [Abstract][Full Text] [Related]
10. [CA 125 regression after two cycles of neoadjuvant chemotherapy as prognostic factor in patients with advanced ovarian cancer and primary peritoneal serous cancer who underwent interval surgical cytoreduction].
Gasowska-Bodnar A; Bodnar L; Wcisło GB; Jerzak MM; Szczylik C; Baranowski W
Ginekol Pol; 2008 Feb; 79(2):108-14. PubMed ID: 18510089
[TBL] [Abstract][Full Text] [Related]
11. Peritoneal serous papillary carcinoma, a phenotypic variant of familial ovarian cancer: implications for ovarian cancer screening.
Karlan BY; Baldwin RL; Lopez-Luevanos E; Raffel LJ; Barbuto D; Narod S; Platt LD
Am J Obstet Gynecol; 1999 Apr; 180(4):917-28. PubMed ID: 10203660
[TBL] [Abstract][Full Text] [Related]
12. Rare clinical manifestations of primary peritoneal serous carcinoma presenting as colorectal cancer: A report of two cases.
Kao TC; Mao TL; Cheng CY; Chen IH; Cheng WF
Taiwan J Obstet Gynecol; 2021 Mar; 60(2):363-366. PubMed ID: 33678344
[TBL] [Abstract][Full Text] [Related]
13. [Clinical management and prognostic analysis of primary peritoneal neoplasms].
Zhang C; Cui H; Zhao Y; Liang XD; Wang CH; Li XP; Shen DH; Wang SJ; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2005 Jul; 40(7):464-8. PubMed ID: 16080873
[TBL] [Abstract][Full Text] [Related]
14. Primary papillary serous carcinoma of the peritoneum: a case of complete remission of bulky peritoneal disease after chemotherapy.
Saleh WA; Van de Ven CJ; Kim W
Henry Ford Hosp Med J; 1992; 40(1-2):136-8. PubMed ID: 1428967
[TBL] [Abstract][Full Text] [Related]
15. Primary peritoneal carcinoma: regional cancer institute experience.
Ifthikar AM; Rathod PS; Shruthi S; Pallavi VR; Shobha K; Shankaranand B; Umadevi K; Bafna UD
Indian J Surg Oncol; 2014 Sep; 5(3):232-6. PubMed ID: 25419074
[TBL] [Abstract][Full Text] [Related]
16. [Successful treatment of primary peritoneal carcinoma with paclitaxel and carboplatin combination chemotherapy].
Tohya T; Ujioka T; Yamaguchi M
Gan To Kagaku Ryoho; 2008 Jan; 35(1):153-5. PubMed ID: 18195548
[TBL] [Abstract][Full Text] [Related]
17. Clinico-pathological outcomes after total parietal peritonectomy, cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in advanced serous papillary peritoneal carcinoma submitted to neoadjuvant systemic chemotherapy- largest single institute experience.
Deraco M; Sinukumar S; Salcedo-Hernández RA; Rajendra VJ; Baratti D; Guaglio M; Nizri E; Kusamura S
Eur J Surg Oncol; 2019 Nov; 45(11):2103-2108. PubMed ID: 31230982
[TBL] [Abstract][Full Text] [Related]
18. A preoperative low cancer antigen 125 level (≤25.8 mg/dl) is a useful criterion to determine the optimal timing of interval debulking surgery following neoadjuvant chemotherapy in epithelial ovarian cancer.
Morimoto A; Nagao S; Kogiku A; Yamamoto K; Miwa M; Wakahashi S; Ichida K; Sudo T; Yamaguchi S; Fujiwara K
Jpn J Clin Oncol; 2016 Jun; 46(6):517-21. PubMed ID: 26977055
[TBL] [Abstract][Full Text] [Related]
19. Peritoneal papillary serous carcinoma: study of 15 cases and comparison with stage III-IV ovarian papillary serous carcinoma.
Piura B; Meirovitz M; Bartfeld M; Yanai-Inbar I; Cohen Y
J Surg Oncol; 1998 Jul; 68(3):173-8. PubMed ID: 9701210
[TBL] [Abstract][Full Text] [Related]
20. Experience with platinum-paclitaxel chemotherapy in the initial management of papillary serous carcinoma of the peritoneum.
Kennedy AW; Markman M; Webster KD; Kulp B; Peterson G; Rybicki LA; Belinson JL
Gynecol Oncol; 1998 Nov; 71(2):288-90. PubMed ID: 9826473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
